Affymetrix CytoScan Dx Assay for postnatal detection of DNA CNVs
The Affymetrix CytoScan Dx Assay is intended for the postnatal detection of DNA copy number variants (CNV) in patients referred for chromosomal testing. It is designed to help physicians diagnose children’s developmental and intellectual disabilities more comprehensively by enabling a high-resolution genome-wide analysis of genetic aberrations.
The product analyses the whole genome in a single assay at very good resolution, improving diagnostic capability. High-resolution analysis can reveal small aberrations not readily seen using traditional techniques.
The company’s For Research Use Only version of the assay is currently available in Australia for both constitutional and cancer cytogenetics research applications.
Phone: 1800 678 242
Navinci NaveniFlex Tissue Red proximity ligation assay kit
The kit enables fluorescence visualisation of protein–protein interactions or...
Bio-Rad Laboratories StarBright Dyes for spectral flow cytometry
The range provides users with more options when designing spectral flow cytometry panels,...
MaxWell Biosystems MaxOne+ HD-MEA Chip
The MaxOne+ HD-MEA Chip provides an upgraded performance and user experience through...
